Consensus Lemonade, Inc. Mexican S.E.

Stocks

LMND *

US52567D1072

Property & Casualty Insurance

End-of-day quote Mexican S.E. Other stock markets 2026-07-09			5-day change	1st Jan Change
1,250.00 ^MXN	-10.71%		+2.88%	-1.57%

Jul. 09	Lemonade Insider Sold Shares Worth $5,780,140, According to a Recent SEC Filing	MT
Jul. 08	Lemonade's Share Rally Leaves Limited Upside Without New Catalysts, Morgan Stanley Says	MT

Evolution of the Average Target: Lemonade, Inc.

Evolution of the Target Price: Lemonade, Inc.

Changes in Analyst Recommendations: Lemonade, Inc.

038725.RQrVpUyLNDi2VAhs2XSqHx9X0ksS8o6J2g1c3KPTMJk.LEzh_w3Ncl7GEko9gzHceHg1mXJ5pdHPimQOpuy4UuotR6OUH7pAZ8IERQ~f086ddf16b145ff9f68cb09c414a1597

Analysts' recommendations: Lemonade, Inc.

Jul. 08	Lemonade's Share Rally Leaves Limited Upside Without New Catalysts, Morgan Stanley Says	MT
Jul. 08	Morgan Stanley Downgrades Lemonade to Equalweight From Overweight, Maintains $75 Price Target	MT
Jun. 08	TD Cowen Raises Lemonade Price Target to $55 From $33, Hold Rating Kept	MT
Mar. 17	Lemonade Shares Rise After Morgan Stanley Upgrade	MT
Mar. 17	Morgan Stanley Upgrades Lemonade to Overweight From Equalweight, Adjusts PTto $85 From $80	MT
Jan. 06	Truist Initiates Lemonade at Buy With $98 Price Target	MT
Dec. 16	Lemonade Shares Rise After Morgan Stanley Upgrade	MT
Dec. 16	Morgan Stanley Upgrades Lemonade to Equalweight From Underweight, Adjusts Price Target to $85 From $53	MT
25-08-13	Cantor Fitzgerald Initiates Coverage on Lemonade With Overweight Rating, $60 Price Target	MT
25-04-08	Lemonade Faces Growth Hurdles Amid Tariffs, Competition, Market Uncertainty, Morgan Stanley Says	MT
25-04-08	Morgan Stanley Downgrades Lemonade to Underweight From Equalweight, Adjusts PT to $24 From $35	MT
24-11-20	Morgan Stanley Upgrades Lemonade to Equalweight From Underweight, Raises Price Target to $42 From $23	MT
24-11-07	Keefe Bruyette & Woods Downgrades Lemonade to Underperform, Price Target is $21	MT
24-10-31	Morgan Stanley Lifts Price Target on Lemonade to $15 From $14, Keeps Underweight Rating	MT
24-05-07	Jefferies Adjusts Price Target on Lemonade to $16 From $14, Maintains Underperform Rating	MT
24-05-01	Morgan Stanley Lifts Price Target on Lemonade to $15 From $14, Keeps Underweight Rating	MT
23-11-07	Morgan Stanley Adjusts Price Target on Lemonade to $12 From $11, Maintains Underweight Rating	MT
23-10-11	Morgan Stanley Adjusts Price Target on Lemonade to $10 From $15, Maintains Underweight Rating	MT
23-09-28	BMO Capital Adjusts Price Target on Lemonade to $9 From $8, Maintains Underperform Rating	MT
23-08-04	Piper Sandler Adjusts Price Target on Lemonade to $17 From $18, Maintains Neutral Rating	MT
23-08-03	Morgan Stanley Lifts Price Target on Lemonade to $15 From $14, Maintains Underweight Rating	MT
23-06-20	Morgan Stanley Initiates Lemonade at Underweight With $14 Price Target, Says Stock Doesn't Reflect Long Path to Profitability	MT
23-05-09	Barclays Adjusts Price Target on Lemonade to $17 From $16, Keeps Equalweight Rating	MT
23-05-04	BofA Securities Adjusts Lemonade's Price Target to $12 From $14, Keeps Underperform Rating	MT
23-04-10	Jefferies Cuts Price Target on Lemonade to $11.50 From $13, Maintains Underperform Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TOKIO MARINE HOLDINGS, INC.					+8.31%
	THE TRAVELERS COMPANIES, INC.					-5.09%
	THE ALLSTATE CORPORATION					-1.84%
	AMERICAN INTERNATIONAL GROUP, INC.					+10.21%
	MS&AD INSURANCE GROUP HOLDINGS, INC.					+4.42%
	FAIRFAX FINANCIAL HOLDINGS LIMITED					+15.39%
	INTACT FINANCIAL CORPORATION					+5.01%
	SOMPO HOLDINGS, INC.					-4.52%
	ARCH CAPITAL GROUP LTD.					+7.29%
	Average					+4.35%
	Weighted average by Cap.					+3.81%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

71.03USD

Average target price

62.44USD

Spread / Average Target

-12.09%

High Price Target

92.00USD

Spread / Highest target

+29.52%

Low Price Target

37.00USD

Spread / Lowest Target

-47.91%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
TD Cowen
Truist Securities
Cantor Fitzgerald
Keefe Bruyette & Woods
Jefferies & Co.
BMO Capital
Piper Sandler
Barclays
BofA Securities
Keefe, Bruyette & Woods
Oppenheimer
JMP Securities
Autonomous Research
Wolfe Research